KalVista Pharmaceuticals (KALV) Change in Cash (2014 - 2025)
KalVista Pharmaceuticals (KALV) reported Change in Cash of -$7.3 million for Q3 2025, down 12486.44% on a YoY basis from N/an in Q3 2024, and up 79.51% sequentially from -$35.7 million in Q2 2025.
KalVista Pharmaceuticals (KALV) Change in Cash (2014 - 2025) Analysis & Trends
KalVista Pharmaceuticals (KALV) has 12 years of Change in Cash data on file, last reported at -$7.3 million in Q3 2025.
- For the quarter ending Q3 2025, Change in Cash fell 12486.44% year-over-year to -$7.3 million; the trailing twelve-month figure through Jul 2025 stood at -$33.2 million (down 88.97% YoY), and the FY2025 full-year result was $100.5 million, up 510.99% from the prior year.
- Change in Cash climbed to -$7.3 million in Q3 2025, from -$35.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $46.5 million in Q1 2023 to a low of -$35.7 million in Q2 2025.
- A 5-year average of -$976111.1 and a median of -$427500.0 in 2022 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash jumped 5183.59% in 2023 and tumbled 12486.44% in 2025, its largest moves.
- Tracing KALV's Change in Cash over 5 years: stood at -$1.9 million in 2021, then soared by 138.98% to $722000.0 in 2022, then jumped by 1043.63% to $8.3 million in 2023, then gained by 17.88% to $9.7 million in 2024, then tumbled by 175.08% to -$7.3 million in 2025.
- Business Quant data shows KALV's Change in Cash at -$7.3 million in Q3 2025, -$35.7 million in Q2 2025, and $9.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -7.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -7.31 Mn |
| Apr 30, 2025 | -35.67 Mn |
| Oct 31, 2024 | 9.73 Mn |
| Jul 31, 2024 | 59,000.00 |
| Apr 30, 2024 | 8.73 Mn |
| Jan 31, 2024 | -34.61 Mn |
| Oct 31, 2023 | 8.26 Mn |
| Jul 31, 2023 | -6.83 Mn |
| Apr 30, 2023 | -28.81 Mn |
| Jan 31, 2023 | 46.46 Mn |
| Oct 31, 2022 | 722,000.00 |
| Jul 31, 2022 | 7.13 Mn |
| Apr 30, 2022 | -14.85 Mn |
| Jan 31, 2022 | -914,000.00 |
| Oct 31, 2021 | -1.85 Mn |
| Jul 31, 2021 | -2.25 Mn |
| Apr 30, 2021 | 32.87 Mn |
| Jan 31, 2021 | 1.55 Mn |
| Oct 31, 2020 | -1.84 Mn |
| Jul 31, 2020 | 2.23 Mn |